Testing breast radiation after lumpectomy with or without hormone pills
Part of Cancer, Skin clinical trials.
This Phase 2 trial compares different “after-surgery” treatment plans for certain older women with hormone-sensitive early breast cancer. It looks at whether a standard hormone-pills approach or a faster, smaller-area radiation approach (given after lumpectomy) works best to prevent cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 65 or older with a new invasive breast cancer found for the first time
- Your tumor is small (T1) and grade 1 or 2 (not high-grade)
- Your cancer tests positive for estrogen and progesterone receptors (ER/PR) and is not HER2-positive
- Your cancer has not spread to lymph nodes that are nearby (N0) and does not have lymphovascular invasion (LVSI)
- After lumpectomy, the surgical edges/margins are at least 2 mm, and your surgeon’s plan fits “APBI” (accelerated partial breast irradiation)
- You cannot be on chemotherapy during the study, and you must be able to stop hormone-blocking drugs (if currently taking) within 30 days of randomization
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
This trial tests a single, targeted radiation treatment given during or after lumpectomy for early-stage breast cancer. It aims to make treatment more convenient while keeping the same safety and effectiveness as longer radiation courses.
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
This trial studies a radiation technique that treats only part of the breast using a faster schedule. It may help some people with early breast cancer after breast-conserving surgery by delivering effective treatment with less radiation to the rest of the breast.
This trial tests a shorter, more intense course of radiation to the whole breast after chemotherapy in women age 60 or older with early-stage breast cancer. It is designed for those who had a lumpectomy and are at higher risk based on genetic tests like Mammaprint or Oncotype.
This trial tests whether giving a second round of radiation to the breast after a lumpectomy for a recurrence is safe and effective. It is for people with a specific type of breast cancer (ER+HER2-) who meet strict criteria regarding prior radiation and tumor characteristics.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.